Benzinga | Aug 4, 2021 04:25PM EDT

Medifast Q2 EPS $3.96 Beats $3.31 Estimate, Sales $394.20M Beat $358.45M Estimate

Medifast (NYSE:MED) reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.31 by 19.64 percent. This is a 102.04 percent increase over earnings of $1.96 per share from the same period last year. The company reported quarterly sales of $394.20 million which beat the analyst consensus estimate of $358.45 million by 9.97 percent. This is a 79.18 percent increase over sales of $220.00 million the same period last year.